Purpose of Screening
- Early diagnosis of axial spondyloarthritis
- Identifying genetic markers (HLA-B27) linked to the disease
- Evaluating systemic inflammation levels
Protect your mobility and regain vitality with early screening for Ankylosing Spondylitis. This comprehensive evaluation identifies chronic back pain causes early, ensuring timely intervention to maintain spine flexibility and joint health.
Scientific name: Ankylosing Spondylitis (AS) Early Screening
A comprehensive screening combining clinical assessment and laboratory testing (HLA-B27) to detect axial spondyloarthritis. It identifies chronic inflammatory back pain early, facilitating effective management and preventing long-term spinal fusion or damage.